ALEXIS LAMIE: Open Payments
NPI 1235805300 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,449 in 52 payments from 20 companies in 2025. Trend: 2023 $669 · 2024 $1,638 · 2025 $1,449
Food & beverage: $1,020Long term medical supply or device loan: $399Education: $31
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $514 |
| AstraZeneca Pharmaceuticals LP | 6 | $141 |
| PFIZER INC. | 4 | $96 |
| Caris MPI, Inc. | 4 | $90 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| BeOne Medicines USA, Inc. | 2 | $62 |
| Janssen Biotech, Inc. | 3 | $62 |
| Aveo Pharmaceuticals, Inc. | 3 | $53 |
| Celgene Corporation | 2 | $45 |
| Gilead Sciences, Inc. | 2 | $38 |
Products named: KISQALI, MI CANCER SEEK, XTANDI, LYNPARZA, Enhertu, IBRANCE, FOTIVDA, LUTATHERA.
Industry payments across AZ — which companies pay providers there.
